CHE vs PACS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 10, 2026
CHE
PACS
Investment Advisor Scores
PACS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CHE | PACS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 18.9394 | 18.7617 | PACS |
| PEG Ratio | 1.8933 | 1.2502 | PACS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 10.6% | 11.5% | PACS |
| Earnings Growth | 22.2% | 15.6% | CHE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 49.2/100 | 35.6/100 | CHE |
| Profit Margin | 10.6% | 4.9% | CHE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | AVOID NEW MONEY | CHE |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CHE
NeutralMixed signals - no dominant trend phase, RSI 60
PACS
MarkupPrice above SMA50, rising 50-day trend (2.9% over 20 days), RSI 58
Fundamentals Snapshot
| Metric | CHE | PACS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 19.6 | 17.5 |
| Trailing P/E | 25.8 | 28.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.3% | 0.2% |
| Operating Margin | 0.2% | 0.1% |
| EPS | 20.88 | 1.73 |
| Dividend Yield | 0.00% | — |